HEADER VIRAL PROTEIN 09-OCT-20 7KDT TITLE HUMAN TOM70 IN COMPLEX WITH SARS COV2 ORF9B COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOCHONDRIAL IMPORT RECEPTOR SUBUNIT TOM70; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MITOCHONDRIAL PRECURSOR PROTEINS IMPORT RECEPTOR,TRANSLOCASE COMPND 5 OF OUTER MEMBRANE 70 KDA SUBUNIT,TRANSLOCASE OF OUTER MITOCHONDRIAL COMPND 6 MEMBRANE PROTEIN 70; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: ORF9B PROTEIN; COMPND 10 CHAIN: B; COMPND 11 SYNONYM: ORF9B,ACCESSORY PROTEIN 9B,ORF-9B,PROTEIN 9B; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TOMM70, KIAA0719, TOM70, TOMM70A; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 10 2; SOURCE 11 ORGANISM_COMMON: 2019-NCOV; SOURCE 12 ORGANISM_TAXID: 2697049; SOURCE 13 GENE: 9B; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 15 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS ORF9B, TOM70, MITOCHONDRIA, VIRUS INFECTION, SARS COV2, VIRAL PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR QCRG STRUCTURAL BIOLOGY CONSORTIUM REVDAT 4 06-MAR-24 7KDT 1 REMARK REVDAT 3 16-DEC-20 7KDT 1 JRNL REVDAT 2 04-NOV-20 7KDT 1 JRNL REVDAT 1 21-OCT-20 7KDT 0 JRNL AUTH D.E.GORDON,J.HIATT,M.BOUHADDOU,V.V.REZELJ,S.ULFERTS, JRNL AUTH 2 H.BRABERG,A.S.JUREKA,K.OBERNIER,J.Z.GUO,J.BATRA,R.M.KAAKE, JRNL AUTH 3 A.R.WECKSTEIN,T.W.OWENS,M.GUPTA,S.POURMAL,E.W.TITUS,M.CAKIR, JRNL AUTH 4 M.SOUCHERAY,M.MCGREGOR,Z.CAKIR,G.JANG,M.J.O'MEARA, JRNL AUTH 5 T.A.TUMMINO,Z.ZHANG,H.FOUSSARD,A.ROJC,Y.ZHOU,D.KUCHENOV, JRNL AUTH 6 R.HUTTENHAIN,J.XU,M.ECKHARDT,D.L.SWANEY,J.M.FABIUS,M.UMMADI, JRNL AUTH 7 B.TUTUNCUOGLU,U.RATHORE,M.MODAK,P.HAAS,K.M.HAAS,Z.Z.C.NAING, JRNL AUTH 8 E.H.PULIDO,Y.SHI,I.BARRIO-HERNANDEZ,D.MEMON,E.PETSALAKI, JRNL AUTH 9 A.DUNHAM,M.C.MARRERO,D.BURKE,C.KOH,T.VALLET,J.A.SILVAS, JRNL AUTH10 C.M.AZUMAYA,C.BILLESBOLLE,A.F.BRILOT,M.G.CAMPBELL,A.DIALLO, JRNL AUTH11 M.S.DICKINSON,D.DIWANJI,N.HERRERA,N.HOPPE,H.T.KRATOCHVIL, JRNL AUTH12 Y.LIU,G.E.MERZ,M.MORITZ,H.C.NGUYEN,C.NOWOTNY,C.PUCHADES, JRNL AUTH13 A.N.RIZO,U.SCHULZE-GAHMEN,A.M.SMITH,M.SUN,I.D.YOUNG,J.ZHAO, JRNL AUTH14 D.ASARNOW,J.BIEL,A.BOWEN,J.R.BRAXTON,J.CHEN,C.M.CHIO, JRNL AUTH15 U.S.CHIO,I.DESHPANDE,L.DOAN,B.FAUST,S.FLORES,M.JIN,K.KIM, JRNL AUTH16 V.L.LAM,F.LI,J.LI,Y.L.LI,Y.LI,X.LIU,M.LO,K.E.LOPEZ,A.A.MELO, JRNL AUTH17 F.R.MOSS 3RD,P.NGUYEN,J.PAULINO,K.I.PAWAR,J.K.PETERS, JRNL AUTH18 T.H.POSPIECH JR.,M.SAFARI,S.SANGWAN,K.SCHAEFER,P.V.THOMAS, JRNL AUTH19 A.C.THWIN,R.TRENKER,E.TSE,T.K.M.TSUI,F.WANG,N.WHITIS,Z.YU, JRNL AUTH20 K.ZHANG,Y.ZHANG,F.ZHOU,D.SALTZBERG,A.J.HODDER, JRNL AUTH21 A.S.SHUN-SHION,D.M.WILLIAMS,K.M.WHITE,R.ROSALES,T.KEHRER, JRNL AUTH22 L.MIORIN,E.MORENO,A.H.PATEL,S.RIHN,M.M.KHALID, JRNL AUTH23 A.VALLEJO-GRACIA,P.FOZOUNI,C.R.SIMONEAU,T.L.ROTH,D.WU, JRNL AUTH24 M.A.KARIM,M.GHOUSSAINI,I.DUNHAM,F.BERARDI,S.WEIGANG, JRNL AUTH25 M.CHAZAL,J.PARK,J.LOGUE,M.MCGRATH,S.WESTON,R.HAUPT, JRNL AUTH26 C.J.HASTIE,M.ELLIOTT,F.BROWN,K.A.BURNESS,E.REID,M.DORWARD, JRNL AUTH27 C.JOHNSON,S.G.WILKINSON,A.GEYER,D.M.GIESEL,C.BAILLIE, JRNL AUTH28 S.RAGGETT,H.LEECH,R.TOTH,N.GOODMAN,K.C.KEOUGH,A.L.LIND, JRNL AUTH29 R.J.KLESH,K.R.HEMPHILL,J.CARLSON-STEVERMER,J.OKI,K.HOLDEN, JRNL AUTH30 T.MAURES,K.S.POLLARD,A.SALI,D.A.AGARD,Y.CHENG,J.S.FRASER, JRNL AUTH31 A.FROST,N.JURA,T.KORTEMME,A.MANGLIK,D.R.SOUTHWORTH, JRNL AUTH32 R.M.STROUD,D.R.ALESSI,P.DAVIES,M.B.FRIEMAN,T.IDEKER,C.ABATE, JRNL AUTH33 N.JOUVENET,G.KOCHS,B.SHOICHET,M.OTT,M.PALMARINI,K.M.SHOKAT, JRNL AUTH34 A.GARCIA-SASTRE,J.A.RASSEN,R.GROSSE,O.S.ROSENBERG,K.A.VERBA, JRNL AUTH35 C.F.BASLER,M.VIGNUZZI,A.A.PEDEN,P.BELTRAO,N.J.KROGAN JRNL TITL COMPARATIVE HOST-CORONAVIRUS PROTEIN INTERACTION NETWORKS JRNL TITL 2 REVEAL PAN-VIRAL DISEASE MECHANISMS. JRNL REF SCIENCE V. 370 2020 JRNL REFN ESSN 1095-9203 JRNL PMID 33060197 JRNL DOI 10.1126/SCIENCE.ABE9403 REMARK 2 REMARK 2 RESOLUTION. 3.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CRYOSPARC, SERIALEM, CRYOSPARC, REMARK 3 ROSETTA, CRYOSPARC, CRYOSPARC, ROSETTA, REMARK 3 ISOLDE REMARK 3 RECONSTRUCTION SCHEMA : FOURIER SPACE REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : 3FP3 REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.050 REMARK 3 NUMBER OF PARTICLES : 178373 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7KDT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-OCT-20. REMARK 100 THE DEPOSITION ID IS D_1000251886. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : ORF9B-TOM70 COMPLEX REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 12.50 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : BLOT FOR 5 SECONDS BEFORE REMARK 245 PLUNGING INTO LIQUID ETHANE REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : 1534 REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6600.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : 105000 REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 273 REMARK 465 LEU A 274 REMARK 465 LYS A 275 REMARK 465 GLY A 276 REMARK 465 GLU A 277 REMARK 465 LYS A 278 REMARK 465 SER A 279 REMARK 465 ASP A 280 REMARK 465 GLU A 281 REMARK 465 ASP A 282 REMARK 465 LYS A 283 REMARK 465 ASP A 284 REMARK 465 LYS A 285 REMARK 465 GLU A 286 REMARK 465 GLY A 287 REMARK 465 GLU A 288 REMARK 465 ALA A 289 REMARK 465 LEU A 290 REMARK 465 GLU A 291 REMARK 465 VAL A 292 REMARK 465 LYS A 293 REMARK 465 GLU A 294 REMARK 465 ASN A 295 REMARK 465 SER A 296 REMARK 465 GLY A 297 REMARK 465 TYR A 601 REMARK 465 GLY A 602 REMARK 465 LEU A 603 REMARK 465 LYS A 604 REMARK 465 PRO A 605 REMARK 465 PRO A 606 REMARK 465 THR A 607 REMARK 465 LEU A 608 REMARK 465 MET B 1 REMARK 465 ASP B 2 REMARK 465 PRO B 3 REMARK 465 LYS B 4 REMARK 465 ILE B 5 REMARK 465 SER B 6 REMARK 465 GLU B 7 REMARK 465 MET B 8 REMARK 465 HIS B 9 REMARK 465 PRO B 10 REMARK 465 ALA B 11 REMARK 465 LEU B 12 REMARK 465 ARG B 13 REMARK 465 LEU B 14 REMARK 465 VAL B 15 REMARK 465 ASP B 16 REMARK 465 PRO B 17 REMARK 465 GLN B 18 REMARK 465 ILE B 19 REMARK 465 GLN B 20 REMARK 465 LEU B 21 REMARK 465 ALA B 22 REMARK 465 VAL B 23 REMARK 465 THR B 24 REMARK 465 ARG B 25 REMARK 465 MET B 26 REMARK 465 GLU B 27 REMARK 465 ASN B 28 REMARK 465 ALA B 29 REMARK 465 VAL B 30 REMARK 465 GLY B 31 REMARK 465 ARG B 32 REMARK 465 ASP B 33 REMARK 465 GLN B 34 REMARK 465 ASN B 35 REMARK 465 ASN B 36 REMARK 465 VAL B 37 REMARK 465 GLY B 38 REMARK 465 GLN B 77 REMARK 465 MET B 78 REMARK 465 THR B 79 REMARK 465 LYS B 80 REMARK 465 LEU B 81 REMARK 465 ALA B 82 REMARK 465 THR B 83 REMARK 465 THR B 84 REMARK 465 GLU B 85 REMARK 465 GLU B 86 REMARK 465 LEU B 87 REMARK 465 PRO B 88 REMARK 465 ASP B 89 REMARK 465 GLU B 90 REMARK 465 PHE B 91 REMARK 465 VAL B 92 REMARK 465 VAL B 93 REMARK 465 VAL B 94 REMARK 465 THR B 95 REMARK 465 VAL B 96 REMARK 465 LYS B 97 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 159 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG A 192 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 ARG A 366 NE - CZ - NH1 ANGL. DEV. = 3.0 DEGREES REMARK 500 ARG A 373 NE - CZ - NH1 ANGL. DEV. = 3.7 DEGREES REMARK 500 ARG A 447 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 ARG A 529 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG B 47 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG B 58 NE - CZ - NH1 ANGL. DEV. = 3.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 183 87.52 -152.85 REMARK 500 ASP A 266 56.78 -91.36 REMARK 500 ASN A 344 54.85 -90.30 REMARK 500 GLN A 399 61.56 -103.73 REMARK 500 GLN A 525 62.33 38.08 REMARK 500 ASN A 573 2.49 -67.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR A 186 0.09 SIDE CHAIN REMARK 500 TYR A 298 0.08 SIDE CHAIN REMARK 500 ARG A 335 0.11 SIDE CHAIN REMARK 500 ARG A 366 0.09 SIDE CHAIN REMARK 500 ARG A 373 0.11 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-22829 RELATED DB: EMDB REMARK 900 HUMAN TOM70 IN COMPLEX WITH SARS COV2 ORF9B DBREF 7KDT A 109 608 UNP O94826 TOM70_HUMAN 109 608 DBREF 7KDT B 1 97 UNP P0DTD2 ORF9B_SARS2 1 97 SEQRES 1 A 500 ASN SER LEU ASP ARG ALA GLN ALA ALA LYS ASN LYS GLY SEQRES 2 A 500 ASN LYS TYR PHE LYS ALA GLY LYS TYR GLU GLN ALA ILE SEQRES 3 A 500 GLN CYS TYR THR GLU ALA ILE SER LEU CYS PRO THR GLU SEQRES 4 A 500 LYS ASN VAL ASP LEU SER THR PHE TYR GLN ASN ARG ALA SEQRES 5 A 500 ALA ALA PHE GLU GLN LEU GLN LYS TRP LYS GLU VAL ALA SEQRES 6 A 500 GLN ASP CYS THR LYS ALA VAL GLU LEU ASN PRO LYS TYR SEQRES 7 A 500 VAL LYS ALA LEU PHE ARG ARG ALA LYS ALA HIS GLU LYS SEQRES 8 A 500 LEU ASP ASN LYS LYS GLU CYS LEU GLU ASP VAL THR ALA SEQRES 9 A 500 VAL CYS ILE LEU GLU GLY PHE GLN ASN GLN GLN SER MET SEQRES 10 A 500 LEU LEU ALA ASP LYS VAL LEU LYS LEU LEU GLY LYS GLU SEQRES 11 A 500 LYS ALA LYS GLU LYS TYR LYS ASN ARG GLU PRO LEU MET SEQRES 12 A 500 PRO SER PRO GLN PHE ILE LYS SER TYR PHE SER SER PHE SEQRES 13 A 500 THR ASP ASP ILE ILE SER GLN PRO MET LEU LYS GLY GLU SEQRES 14 A 500 LYS SER ASP GLU ASP LYS ASP LYS GLU GLY GLU ALA LEU SEQRES 15 A 500 GLU VAL LYS GLU ASN SER GLY TYR LEU LYS ALA LYS GLN SEQRES 16 A 500 TYR MET GLU GLU GLU ASN TYR ASP LYS ILE ILE SER GLU SEQRES 17 A 500 CYS SER LYS GLU ILE ASP ALA GLU GLY LYS TYR MET ALA SEQRES 18 A 500 GLU ALA LEU LEU LEU ARG ALA THR PHE TYR LEU LEU ILE SEQRES 19 A 500 GLY ASN ALA ASN ALA ALA LYS PRO ASP LEU ASP LYS VAL SEQRES 20 A 500 ILE SER LEU LYS GLU ALA ASN VAL LYS LEU ARG ALA ASN SEQRES 21 A 500 ALA LEU ILE LYS ARG GLY SER MET TYR MET GLN GLN GLN SEQRES 22 A 500 GLN PRO LEU LEU SER THR GLN ASP PHE ASN MET ALA ALA SEQRES 23 A 500 ASP ILE ASP PRO GLN ASN ALA ASP VAL TYR HIS HIS ARG SEQRES 24 A 500 GLY GLN LEU LYS ILE LEU LEU ASP GLN VAL GLU GLU ALA SEQRES 25 A 500 VAL ALA ASP PHE ASP GLU CYS ILE ARG LEU ARG PRO GLU SEQRES 26 A 500 SER ALA LEU ALA GLN ALA GLN LYS CYS PHE ALA LEU TYR SEQRES 27 A 500 ARG GLN ALA TYR THR GLY ASN ASN SER SER GLN ILE GLN SEQRES 28 A 500 ALA ALA MET LYS GLY PHE GLU GLU VAL ILE LYS LYS PHE SEQRES 29 A 500 PRO ARG CYS ALA GLU GLY TYR ALA LEU TYR ALA GLN ALA SEQRES 30 A 500 LEU THR ASP GLN GLN GLN PHE GLY LYS ALA ASP GLU MET SEQRES 31 A 500 TYR ASP LYS CYS ILE ASP LEU GLU PRO ASP ASN ALA THR SEQRES 32 A 500 THR TYR VAL HIS LYS GLY LEU LEU GLN LEU GLN TRP LYS SEQRES 33 A 500 GLN ASP LEU ASP ARG GLY LEU GLU LEU ILE SER LYS ALA SEQRES 34 A 500 ILE GLU ILE ASP ASN LYS CYS ASP PHE ALA TYR GLU THR SEQRES 35 A 500 MET GLY THR ILE GLU VAL GLN ARG GLY ASN MET GLU LYS SEQRES 36 A 500 ALA ILE ASP MET PHE ASN LYS ALA ILE ASN LEU ALA LYS SEQRES 37 A 500 SER GLU MET GLU MET ALA HIS LEU TYR SER LEU CYS ASP SEQRES 38 A 500 ALA ALA HIS ALA GLN THR GLU VAL ALA LYS LYS TYR GLY SEQRES 39 A 500 LEU LYS PRO PRO THR LEU SEQRES 1 B 97 MET ASP PRO LYS ILE SER GLU MET HIS PRO ALA LEU ARG SEQRES 2 B 97 LEU VAL ASP PRO GLN ILE GLN LEU ALA VAL THR ARG MET SEQRES 3 B 97 GLU ASN ALA VAL GLY ARG ASP GLN ASN ASN VAL GLY PRO SEQRES 4 B 97 LYS VAL TYR PRO ILE ILE LEU ARG LEU GLY SER PRO LEU SEQRES 5 B 97 SER LEU ASN MET ALA ARG LYS THR LEU ASN SER LEU GLU SEQRES 6 B 97 ASP LYS ALA PHE GLN LEU THR PRO ILE ALA VAL GLN MET SEQRES 7 B 97 THR LYS LEU ALA THR THR GLU GLU LEU PRO ASP GLU PHE SEQRES 8 B 97 VAL VAL VAL THR VAL LYS HELIX 1 AA1 ASN A 109 ALA A 127 1 19 HELIX 2 AA2 LYS A 129 CYS A 144 1 16 HELIX 3 AA3 PRO A 145 ASN A 149 5 5 HELIX 4 AA4 LEU A 152 LEU A 166 1 15 HELIX 5 AA5 LYS A 168 ASN A 183 1 16 HELIX 6 AA6 TYR A 186 LEU A 200 1 15 HELIX 7 AA7 ASN A 202 GLU A 217 1 16 HELIX 8 AA8 ASN A 221 LYS A 245 1 25 HELIX 9 AA9 SER A 253 SER A 262 1 10 HELIX 10 AB1 LEU A 299 GLU A 307 1 9 HELIX 11 AB2 ASN A 309 ASP A 311 5 3 HELIX 12 AB3 LYS A 312 ILE A 321 1 10 HELIX 13 AB4 GLU A 324 GLY A 343 1 20 HELIX 14 AB5 ASN A 344 LEU A 358 1 15 HELIX 15 AB6 ASN A 362 GLN A 380 1 19 HELIX 16 AB7 GLN A 382 ASP A 397 1 16 HELIX 17 AB8 ASN A 400 LEU A 414 1 15 HELIX 18 AB9 GLN A 416 ARG A 431 1 16 HELIX 19 AC1 SER A 434 GLY A 452 1 19 HELIX 20 AC2 ASN A 454 PHE A 472 1 19 HELIX 21 AC3 CYS A 475 GLN A 489 1 15 HELIX 22 AC4 GLN A 491 GLU A 506 1 16 HELIX 23 AC5 ASN A 509 LEU A 521 1 13 HELIX 24 AC6 ASP A 526 ASP A 541 1 16 HELIX 25 AC7 CYS A 544 ARG A 558 1 15 HELIX 26 AC8 ASN A 560 ASN A 573 1 14 HELIX 27 AC9 SER A 577 LYS A 599 1 23 HELIX 28 AD1 PRO B 51 PHE B 69 1 19 HELIX 29 AD2 THR B 72 VAL B 76 5 5 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000